{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:03:27Z","timestamp":1769047407099,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.japh.2025.102382","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:22:44Z","timestamp":1740684164000},"page":"102382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and implementation of a best practice alerting process for naloxone prescribing at rural community pharmacies in Wisconsin: A pilot study"],"prefix":"10.1016","volume":"65","author":[{"given":"Sura O.","family":"AlMahasis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha A.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102382_bib6","author":"Chou"},{"issue":"4","key":"10.1016\/j.japh.2025.102382_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Non-randomized intervention study of naloxone co-prescription for primary care patients on long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.japh.2025.102382_bib8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addict Abingdon Engl"},{"key":"10.1016\/j.japh.2025.102382_bib10","first-page":"67","article-title":"The role of community pharmacy-based vaccination in the USA: current practice and future directions","volume":"4","author":"Bach","year":"2015","journal-title":"Integr Pharm Res Pract"},{"issue":"7494","key":"10.1016\/j.japh.2025.102382_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.38398.500764.8F","article-title":"Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success","volume":"330","author":"Kawamoto","year":"2005","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.japh.2025.102382_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s11606-017-4046-6","article-title":"Using active choice within the electronic health record to increase influenza vaccination rates","volume":"32","author":"Patel","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2025.102382_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11606-017-4286-5","article-title":"Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments","volume":"33","author":"Delgado","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2025.102382_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s11606-019-05302-1","article-title":"Impact of a state opioid prescribing limit and electronic medical record alert on opioid prescriptions: a difference-in-differences analysis","volume":"35","author":"Lowenstein","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2025.102382_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.17294\/2330-0698.1619","article-title":"Using clinical decision support within the electronic health record to reduce incorrect prescribing for acute sinusitis","volume":"5","author":"Ginzburg","year":"2018","journal-title":"J Patient-Centered Res Rev"},{"key":"10.1016\/j.japh.2025.102382_bib17","author":"Maurer"},{"issue":"9","key":"10.1016\/j.japh.2025.102382_bib18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/add.14664","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.japh.2025.102382_bib19","article-title":"Effectiveness of policies for addressing the us opioid epidemic: a model-based analysis from the Stanford-Lancet Commission on the North American opioid crisis","volume":"3","author":"Rao","year":"2021","journal-title":"Lancet Reg Health - Am"},{"issue":"10","key":"10.1016\/j.japh.2025.102382_bib20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the US opioid epidemic","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.japh.2025.102382_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.japh.2019.06.016","article-title":"Pharmacist roles, training, and perceived barriers in naloxone dispensing: a systematic review","volume":"60","author":"Thakur","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.japh.2025.102382_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0897190020980626","article-title":"Community pharmacists roles during the COVID-19 pandemic","volume":"35","author":"Hess","year":"2020","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.japh.2025.102382_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08897077.2017.1391924","article-title":"Barriers and facilitators to dispensing of intranasal naloxone by pharmacists","volume":"39","author":"Bakhireva","year":"2018","journal-title":"Subst Abuse"},{"issue":"2, Supplement","key":"10.1016\/j.japh.2025.102382_bib24","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2025.102382_bib25","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.japh.2018.04.025","article-title":"Identifying barriers to dispensing naloxone: a survey of community pharmacists in North Carolina","volume":"58","author":"Rudolph","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"12","key":"10.1016\/j.japh.2025.102382_bib26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s11606-015-3394-3","article-title":"Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff","volume":"30","author":"Binswanger","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2025.102382_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11606-016-3895-8","article-title":"Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain","volume":"32","author":"Mueller","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.japh.2025.102382_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40264-020-00923-6","article-title":"Rates and costs of dispensing naloxone to patients at high risk for opioid overdose in the United States, 2014\u20132018","volume":"43","author":"Barenie","year":"2020","journal-title":"Drug Saf"},{"issue":"4, Supplement","key":"10.1016\/j.japh.2025.102382_bib29","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.japh.2021.11.032","article-title":"The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol","volume":"62","author":"Coffman","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.japh.2025.102382_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drugpo.2019.09.008","article-title":"Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA","volume":"74","author":"Bessen","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2025.102382_bib31","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1016\/j.jemermed.2024.05.016","article-title":"Factors associated with take home naloxone refusal among emergency department patients participating in an opioid overdose prevention program","volume":"67","author":"O'Brien-Lambert","year":"2024","journal-title":"J Emerg Med"},{"issue":"8","key":"10.1016\/j.japh.2025.102382_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2663","article-title":"Trends in out-of-pocket costs for naloxone by drug brand and payer in the US, 2010-2018","volume":"3","author":"Peet","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.japh.2025.102382_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1213\/ANE.0000000000005976","article-title":"Assessment of a naloxone coprescribing alert for patients at risk of opioid overdose: a quality improvement project","volume":"135","author":"Nelson","year":"2022","journal-title":"Anesth Analg"},{"issue":"2, Supplement","key":"10.1016\/j.japh.2025.102382_bib34","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.japh.2017.01.002","article-title":"Implementing an overdose education and naloxone distribution program in a health system","volume":"57","author":"Devries","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.japh.2025.102382_bib35","doi-asserted-by":"crossref","DOI":"10.5888\/pcd19.220028","article-title":"Evaluation of a program to screen patients in community pharmacies for opioid misuse and accidental overdose","volume":"19","author":"Skoy","year":"2022","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"10.1016\/j.japh.2025.102382_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008292","article-title":"Reimagining evidence generation for heart failure and the role of integrated health care systems","volume":"15","author":"Ahmad","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"10.1016\/j.japh.2025.102382_bib37","first-page":"CD001174","article-title":"Manually-generated reminders delivered on paper: effects on professional practice and patient outcomes","volume":"2019","author":"Pantoja","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.japh.2025.102382_bib38","doi-asserted-by":"crossref","DOI":"10.2196\/22411","article-title":"Reasons people who use opioids do not accept or carry No-cost naloxone: qualitative interview study","volume":"4","author":"Bennett","year":"2020","journal-title":"JMIR Form Res"},{"issue":"10","key":"10.1016\/j.japh.2025.102382_bib39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","article-title":"Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness","volume":"65","author":"Barry","year":"2014","journal-title":"Psychiatr Serv Wash DC"},{"key":"10.1016\/j.japh.2025.102382_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.japh.2025.102382_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12954-020-00375-2","article-title":"Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico","volume":"17","author":"Salvador","year":"2020","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2025.102382_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.japh.2021.08.020","article-title":"Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study","volume":"62","author":"Pollini","year":"2022","journal-title":"J Am Pharm Assoc JAPhA"},{"key":"10.1016\/j.japh.2025.102382_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2018.03.032","article-title":"Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016","volume":"188","author":"Meyerson","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2025.102382_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2019.09.021","article-title":"Attitudes and availability: a comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama","volume":"74","author":"Sisson","year":"2019","journal-title":"Int J Drug Policy"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:15:01Z","timestamp":1762550101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1544319125000615"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102382","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and implementation of a best practice alerting process for naloxone prescribing at rural community pharmacies in Wisconsin: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102382"}}